NCT07011056 2025-09-19
A Phase III Clinical Study of Purinostat Mesylate for Injection in Patients With Diffuse Large B-cell Lymphoma
Chengdu Zenitar Biomedical Technology Co., Ltd
Phase 3 Recruiting
Chengdu Zenitar Biomedical Technology Co., Ltd
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.